Check-in as promised in the title: is it normal to get muscle cramps at week 88. Nothing containing this compound is approved anywhere. Research-use-only material is…
u/kaia_wojcik
Contributes reviews on supplier material. Based in Bochum.
member · joined 12 Mar 2025
Overview — page 2 of 2
comment on is it normal to get muscle cramps at week 88 in c/survodutide · 0 points · 1 year ago
Which endpoint — histological response, fibrosis improvement, or fat fraction?
comment on is it normal to get muscle cramps at week 88 in c/survodutide · 1 points · 1 year ago
Small fix — dual agonist, GLP-1 and glucagon. No GIP arm in this molecule.
comment on is it normal to get muscle cramps at week 88 in c/survodutide · 129 points · 1 year ago
Correcting myself: the readout I quoted was the 4-week interim rather than the endpoint.
comment on how much of what we believe about dual agonist actually comes from GIP threads in c/tirzepatide · 279 points · 1 year ago
23kg over 69 weeks, never went past 10mg, and constipation stayed mild the whole way. Posting because the loud threads are all 15mg.
comment on how much of what we believe about dual agonist actually comes from GIP threads in c/tirzepatide · 96 points · 1 year ago
Not sure that follows.
Saving this one. It is the clearest statement of the stall problem I have read here.
comment on how much of what we believe about dual agonist actually comes from GIP threads in c/tirzepatide · 404 points · 1 year ago
week 5 is early to draw any conclusion at all
The title is the whole question — how much of what we believe about dual agonist actually comes from GIP threads — but here is why I am asking. The distribution matters…
comment on [Results] 12 weeks on 1.7mg, full numbers, ask me anything boring in c/progresspics · -28 points · 1 year ago
Body weight varies by a couple of kilos day to day through fluid, glycogen and gut content, which is why a single weigh-in is noise and a fortnightly trend is signal.
comment on help me understand 15mg, I have read the wiki twice in c/tirzepatide · 0 points · 1 year ago
sulphur burps are the signature complaint and they are not dangerous
comment on [Question] how do you actually verify timeframe in c/progresspics · 38 points · 1 year ago
Agreed — text only was the best rule this board ever adopted. The posts are about what actually changed rather than about lighting.
comment on [Question] how do you actually verify timeframe in c/progresspics · 55 points · 1 year ago
That is a waist measurement, not a weight, and the thread has been comparing them as though they were the same.
comment on why does nobody talk about survodutide in c/survodutide · 7 points · 1 year ago
dual GLP-1 and glucagon agonist, and the glucagon arm is the story
comment on glucagon is the most under-discussed thing on this board in c/survodutide · 0 points · 1 year ago
This is the framing the board needs.
Disagreeing with this bit: that number comes from a different programme with a different population.
comment on small win: dual agonist stopped being a problem at week 50 in c/tirzepatide · 22 points · 1 year ago
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
comment on small win: glucagon stopped being a problem at week 36 in c/survodutide · 186 points · 2 years ago
Went slowly because everything published describes a deliberate escalation. That is the extent of what I will say about it.
comment on [Meta] the goal rule is doing its job and people should stop complaining in c/progresspics · 172 points · 2 years ago
Right — the non-scale victories are the ones I remember. The numbers all blur together after a while.
comment on milestone — 11 things I got wrong before I got it right in c/progresspics · 18 points · 2 years ago
nobody owes anybody a starting weight
Agreed — measurements over photographs, every time, for anybody trying to actually track something.
comment on [Lab] split one vial across Medutest and Janoshik — 98.3% and 98.7% in c/tirzepatide · 394 points · 2 years ago
SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.
comment on the Mounjaro thing finally clicked for me and I want to write it down in c/tirzepatide · 120 points · 2 years ago
Cosigning the four-week thing. It is a minimum interval, and treating it as a schedule to keep up with is how people end up miserable at 12.5.